Citation: Min Zhao, Huan-Ni Liu, Hai-Xin Xie, Hao-Yuan Yu, Jing-Song Yang, Na-Hui Liu, Jia-Qi Chen, Lu-Xin Qie, Zi-Juan Yi, Tian-Jiao Zhou, Lei Xing, Xian Wu Cheng, Yi Wang, Hu-Lin Jiang. Mitochondria-targeted lipid nanoparticles to rescue mitochondrial complex Ⅰ deficiency for Leber's hereditary optic neuropathy therapy[J]. Chinese Chemical Letters, ;2026, 37(12): 112360. doi: 10.1016/j.cclet.2026.112360 shu

Mitochondria-targeted lipid nanoparticles to rescue mitochondrial complex Ⅰ deficiency for Leber's hereditary optic neuropathy therapy

Min Zhao ^a ,
Huan-Ni Liu ^a ,
Hai-Xin Xie ^a ,
Hao-Yuan Yu ^a ,
Jing-Song Yang ^a ,
Na-Hui Liu ^a ,
Jia-Qi Chen ^a ,
Lu-Xin Qie ^a ,
Zi-Juan Yi ^a ,
Tian-Jiao Zhou ^a ,
Lei Xing ^a ,
Xian Wu Cheng ^{b, *,} ,
Yi Wang ^{a, *,} ,
Hu-Lin Jiang ^{a, b, c, d, *,}

a.
State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China
b.
Jilin Provincial Key Laboratory of Stress and Cardiovascular Disease, Department of Cardiology and Hypertension, Yanbian University Hospital, Yanji 133002, China
c.
Joint International Research Laboratory of Target Discovery and New Drug Innovation, MOE, China Pharmaceutical University, Nanjing 210009, China
d.
Department of Precision Medicine, School of Medicine, Sungkyunkwan University, Suwon 16419, South Korea

chengxw@ybu.edu.cn

wangyi950825@163.com

jianghulin3@163.com

Received Date: 16 October 2025
Revised Date: 29 December 2025
Accepted Date: 3 January 2026
Available Online: 5 January 2026

Figures(5)

Mitochondrial gene delivery for functional compensation of defective proteins represents a promising therapeutic strategy for currently untreatable mitochondrial disorders. However, the double-membrane structure of mitochondrial poses a fundamental barrier for the transport of genetic therapeutics into the organelle. Here, we report a novel mitochondria-targeted fluorinated lipid nanoparticle (F₆ mtLNP) for efficient mitochondrial gene delivery. F₆ mtLNP successfully overcame mitochondrial barriers and delivered the therapeutic NDI1 gene into the mitochondrial matrix leveraging the mitochondrial targeting capacity of the mitochondrial targeting signal (MTS) peptide combined with the superior membrane affinity and penetration capability of F₆ lipid. In a rotenone-induced Leber's hereditary optic neuropathy (LHON) model characterized by complex Ⅰ deficiency, F₆ mtLNP mediated superior functional protein expression, leading to significant restoration of complex Ⅰ activity and consequent amelioration of disease symptoms. Collectively, our findings established F₆ mtLNP as a promising platform to overcome the mitochondrial membrane barrier for effective functional gene delivery, offering a potential therapeutic strategy for LHON and other mitochondrial complex Ⅰ deficiency-related mitochondrial disorders.
- Mitochondria-targeted delivery,
- Lipid nanoparticle,
- Ionizable lipid,
- Mitochondrial complex Ⅰ deficiency,
- Mitochondrial disorders
1. [1]
  J. Zhu, K.R. Vinothkumar, J. Hirst, Nature 536 (2016) 354–358. doi: 10.1038/nature19095
2. [2]
  L.Y. Meng, G.Z. Wu, RSC Adv. 13 (2023) 20476–20485. doi: 10.1039/d3ra03313a
3. [3]
  P. Yu-Wai-Man, P.G. Griffiths, G. Hudson, et al., J. Med. Genet. 46 (2009) 145–158. doi: 10.1136/jmg.2007.054270
4. [4]
  J.L. Li, T.Y. Lin, P.L. Chen, et al., Front. Mol. Neurosci. 14 (2021) 797833. doi: 10.3389/fnmol.2021.797833
5. [5]
  B.B. Seo, T. Kitajima-Ihara, E.K. Chan, et al., Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9167–9171. doi: 10.1073/pnas.95.16.9167
6. [6]
  N. Chadderton, A. Palfi, S. Millington-Ward, et al., Eur. J. Hum. Genet. 21 (2013) 62–68. doi: 10.1038/ejhg.2012.112
7. [7]
  N. Chadderton, A. Palfi, D.M. Maloney, et al., Pharmaceutics 15 (2023) 322. doi: 10.3390/pharmaceutics15020322
8. [8]
  S. Millington-Ward, A. Palfi, C. Shortall, et al., Int. J. Mol. Sci. 25 (2024) 8876. doi: 10.3390/ijms25168876
9. [9]
  H. Li, B. Sun, Y. Huang, et al., Mol. Med. 28 (2022) 29.
10. [10]
  H. Yin, R.L. Kanasty, A.A. Eltoukhy, et al., Nat. Rev. Genet. 15 (2014) 541. doi: 10.1038/nrg3763
11. [11]
  G.N. Nguyen, J.K. Everett, S. Kafle, et al., Nat. Biotechnol. 39 (2021) 47. doi: 10.1038/s41587-020-0741-7
12. [12]
  S. Guan, A. Munder, S. Hedtfeld, et al., Nat. Biotechnol. 14 (2019) 287–297. doi: 10.1038/s41565-018-0358-x
13. [13]
  H. Yu, V. Porciatti, A. Lewin, et al., Sci. Rep. 3 (2018) 8.
14. [14]
  Y. Wang, J.S. Yang, M. Zhao, et al., Adv. Drug Deliv. Rev. 211 (2024) 115355. doi: 10.1016/j.addr.2024.115355
15. [15]
  P. Ning, W.J. Wang, M. Chen, et al., Chin. Chem. Lett. 28 (2017) 1943–1951. doi: 10.1016/j.cclet.2017.09.026
16. [16]
  Z.Y. Yu, X. Luo, C. Zhang, et al., Chin. Chem. Lett. 35 (2024) 109519. doi: 10.1016/j.cclet.2024.109519
17. [17]
  Y. Yamada, M. Hibino Satrialdi, et al., Adv. Drug Deliv. Rev. 154-155 (2020) 187–209. doi: 10.1016/j.addr.2020.09.010
18. [18]
  F. Tong, Y. Wang, Y. Xu, et al., Nat. Commun. 15 (2024) 10382. doi: 10.1038/s41467-024-54854-2
19. [19]
  J. Zielonka, J. Joseph, A. Sikora, et al., Chem. Rev. 117 (2017) 10043–10120. doi: 10.1021/acs.chemrev.7b00042
20. [20]
  S.S. Liew, X. Qin, J. Zhou, et al., Angew. Chem. Int. Ed. 60 (2021) 2232–2256. doi: 10.1002/anie.201915826
21. [21]
  L.H. Huang, Z.H. Sun, Q. Shen, et al., Chin. Chem. Lett. 33 (2022) 4146–4156. doi: 10.1016/j.cclet.2022.02.047
22. [22]
  N. Yoshinaga, T. Miyamoto, M. Odahara, et al., Adv. Funct. Mater. 34 (2024) 2306070. doi: 10.1002/adfm.202306070
23. [23]
  Y. Wang, L.F. Hu, P.F. Cui, et al., Adv. Mater. 33 (2021) e2103307. doi: 10.1002/adma.202103307
24. [24]
  C. Zhang, K. Yan, C.K. Fu, et al., Chem. Rev. 122 (2022) 167–208. doi: 10.1021/acs.chemrev.1c00632
25. [25]
  J.H. Gong, Y. Wang, L. Xing, et al., Int. J. Pharm. 535 (2018) 180–193. doi: 10.1016/j.ijpharm.2017.11.015
26. [26]
  H. Han, J. Xing, W. Chen, et al., Nat. Commun. 14 (2023) 944. doi: 10.1038/s41467-023-36625-7
27. [27]
  Z. Zhang, W. Shen, J. Ling, et al., Nat. Commun. 9 (2018) 1377. doi: 10.1038/s41467-018-03779-8
28. [28]
  A. Raza, R. Zhang, R.N. Lu, et al., Nanomedicine 20 (2025) 2545–2569. doi: 10.1080/17435889.2025.2555507
29. [29]
  D. Lyrawati, A. Trounson, D. Cram, Pharm. Res. 28 (2011) 2848–2862. doi: 10.1007/s11095-011-0544-0
30. [30]
  Y. Yamada, T. Ishikawa, H. Harashima, Biomaterials 136 (2017) 56–66. doi: 10.1016/j.biomaterials.2017.05.016
31. [31]
  T. Ishikawa, K. Somiya, R. Munechika, et al., J. Control. Release 274 (2018) 109–117. doi: 10.1016/j.jconrel.2018.02.005
32. [32]
  S. Yang, S.Q. Ma, X. Wan, et al., EBioMedicine 10 (2016) 258–268. doi: 10.1016/j.ebiom.2016.07.002
33. [33]
  Y. Zhang, X. Li, J. Yuan, et al., Clin. Exp. Ophthalmol. 47 (2019) 774–778. doi: 10.1111/ceo.13515
34. [34]
  E. Samaridou, J. Heyes, P. Lutwyche, Adv. Drug Deliv. Rev. 154 (2020) 37–63.
35. [35]
  J.L. Guo, M.R. Gu, Y.H. Chen, et al., Chin. Chem. Lett. 36 (2025) 110849. doi: 10.1016/j.cclet.2025.110849
36. [36]
  E. Voke, M.L. Arral, H.J. Squire, et al., Nat. Commun. 16 (2025) 8699. doi: 10.1038/s41467-025-63726-2
37. [37]
  R. Rampado, S. Crotti, P. Caliceti, et al., Front. Bioeng. Biotechnol. 8 (2020) 166. doi: 10.3389/fbioe.2020.00166
38. [38]
  L.Y. Qi, Y. Wang, L.F. Hu, et al., J. Control. Release 341 (2022) 511–523. doi: 10.1016/j.jconrel.2021.11.046
39. [39]
  M.L. Zhou, S. Liang, J. Wang, et al., Adv. Funct. Mater. 35 (2025) 2414918. doi: 10.1002/adfm.202414918
40. [40]
  M.A. Islam, T. Park, J. Firdous, et al., Prog. Mater. Sci. 128 (2022) 100961. doi: 10.1016/j.pmatsci.2022.100961
41. [41]
  X. Yuan, B. Qin, H. Yin, et al., ACS Cent. Sci. 6 (2020) 174–188. doi: 10.1021/acscentsci.9b01052
42. [42]
  S. Chatterjee, E. Kon, P. Sharma, et al., Proc. Natl. Acad. Sci. U. S. A. 121 (2024) e2307800120. doi: 10.1073/pnas.2307800120
43. [43]
  J. Lv, H. Wang, G. Rong, et al., Acc. Chem. Res. 55 (2022) 722–733. doi: 10.1021/acs.accounts.1c00766
44. [44]
  Y.X. Zhou, J. Wei, G. Deng, et al., Nat. Cell Biol. 25 (2023) 937–949. doi: 10.1038/s41556-023-01160-6
45. [45]
  M. Zheng, Y. Liu, Y. Wang, et al., Adv. Mater. 31 (2019) e1903277. doi: 10.1002/adma.201903277
46. [46]
  R.D. Koilkonda, H. Yu, T.H. Chou, et al., JAMA Ophthalmol. 132 (2014) 409–420. doi: 10.1001/jamaophthalmol.2013.7630
47. [47]
  M.A.E. van de Wal, M.J.W. Adjobo-Hermans, J. Keijer, et al., Brain 145 (2022) 45–63. doi: 10.1093/brain/awab426
48. [48]
  Y. Wang, N.H. Liu, L.F. Hu, et al., Acta Pharm. Sin. B 14 (2024) 5435–5450. doi: 10.1016/j.apsb.2024.08.007
49. [49]
  Y. Aoyama, S. Inagaki, K. Aoshima, et al., J. Pharmacol. Sci. 147 (2021) 200–207. doi: 10.1016/j.jphs.2021.07.003
50. [50]
  D. Kampjut, L.A. Sazanov, Science 370 (2020) eabc4209. doi: 10.1126/science.abc4209
51. [51]
  E.T. Tsai, S.Y. Peng, Y.R. Wu, et al., Cells 12 (2023) 2617. doi: 10.3390/cells12222617
1. [1]
  Haoran Xu , Jiaqi Fan , Jiwei Liu , Qi Wei , Ruoshui Li , Pengcheng Yuan , Bing Xiao , Ying Piao , Wenjing Sun , Jiajia Xiang , Shiqun Shao , Zhuxian Zhou , Youqing Shen , Nigel K.H. Slater , Jianbin Tang . Tetra-branched ionizable lipids enhance the stability and transfection efficiency of lipid nanoparticles for mRNA delivery. Chinese Chemical Letters, 2025, 36(11): 110833-. doi: 10.1016/j.cclet.2025.110833
2. [2]
  Cheng Huang , Wanqin Zeng , Kunhong Zhong , Xing Duan , Yi Liu , Qingqing Tian , Liangxue Zhou , Yuelong Wang , Chunlai Nie , Aiping Tong . A novel ionizable lipid nanoparticle platform for circular RNA-encoded PD-L1×CD3 bispecific antibodies elicits potent antitumor immunity. Chinese Chemical Letters, 2026, 37(8): 112322-. doi: 10.1016/j.cclet.2025.112322
3. [3]
  Jialin Guo , Mingrui Gu , Yahui Chen , Tao Xiong , Yiyang Zhang , Simin Chen , Mingle Li , Xiaoqiang Chen , Xiaojun Peng . Nucleic acid delivery by lipid nanoparticles for organ targeting. Chinese Chemical Letters, 2025, 36(11): 110849-. doi: 10.1016/j.cclet.2025.110849
4. [4]
  Yan-Qi Zhao , Zi-Jian Cheng , Dian Cai , Yue-Lin Fang , Jian Xu , Hong-Lan Dai , Wen-Qi Liu , Xin-Xin Zhang . Nanostructured lipid-based adjuvants and delivery systems for antiviral vaccine development. Chinese Chemical Letters, 2026, 37(9): 112059-. doi: 10.1016/j.cclet.2025.112059
5. [5]
  Zhengyi Shi , Jie Yin , Yang Xiao , Zhangrong Hou , Fei Song , Jianping Wang , Qingyi Tong , Changxing Qi , Yonghui Zhang . Unprecedented sesquiterpene-polycyclic polyprenylated acylphloroglucinol adduct against acute myeloid leukemia via inhibiting mitochondrial complex Ⅴ. Chinese Chemical Letters, 2024, 35(10): 109458-. doi: 10.1016/j.cclet.2023.109458
6. [6]
  Shuangshuang GAI , Jixiang CAI , Moya YANG , Haijuan WU , Shuzhen FENG , Ming JIANG . Endoplasmic reticulum stress and mitochondrial apoptosis in thiosemicarbazone copper(Ⅱ) complex-triggered triple-negative breast cancer cell death. Chinese Journal of Inorganic Chemistry, 2026, 42(5): 1073-1084. doi: 10.11862/CJIC.20250328
7. [7]
  Huamei Zhang , Jingjing Liu , Mingyue Li , Shida Ma , Xucong Zhou , Aixia Meng , Weina Han , Jin Zhou . Imaging polarity changes in pneumonia and lung cancer using a lipid droplet-targeted near-infrared fluorescent probe. Chinese Chemical Letters, 2024, 35(12): 110020-. doi: 10.1016/j.cclet.2024.110020
8. [8]
  Zhoupeng Zheng , Shengyi Gong , Qianhua Li , Shiya Zhang , Guoqiang Feng . Lipid droplets and gallbladder targeted fluorescence probe for ratiometric NO imaging in gallstones disease models. Chinese Chemical Letters, 2025, 36(5): 110191-. doi: 10.1016/j.cclet.2024.110191
9. [9]
  Luyu Zhang , Zirong Dong , Shuai Yu , Guangyue Li , Weiwen Kong , Wenjuan Liu , Haisheng He , Yi Lu , Wei Wu , Jianping Qi . Ionic liquid-based in situ dynamically self-assembled cationic lipid nanocomplexes (CLNs) for enhanced intranasal siRNA delivery. Chinese Chemical Letters, 2024, 35(7): 109101-. doi: 10.1016/j.cclet.2023.109101
10. [10]
  Yunjie Dang , Yanru Feng , Xiao Chen , Chaoxing He , Shujie Wei , Dingyang Liu , Jinlong Qi , Huaxing Zhang , Shaokun Yang , Zhiyun Niu , Bai Xiang . Development of a multi-level pH-responsive lipid nanoplatform for efficient co-delivery of siRNA and small-molecule drugs in tumor treatment. Chinese Chemical Letters, 2024, 35(12): 109660-. doi: 10.1016/j.cclet.2024.109660
11. [11]
  Quan Lu , Lulu Zhang , Zihan Chen , Jiajia Lv , Jie Gao , Xinmin Li , Hongyu Li , Wen Shi , Xiaohua Li , Huimin Ma , Zeli Yuan . A lipid droplet-targeting fluorescence probe for monitoring of lipid peroxidation in ferroptosis and non-alcoholic fatty liver disease. Chinese Chemical Letters, 2025, 36(8): 110620-. doi: 10.1016/j.cclet.2024.110620
12. [12]
  Jing Qian , Guoxing Ling , Yue Li , Yan Liu , Xiaoxuan Guan , Zuyuan Huang , Ming Gao , Cheng Luo , Baoshi Zheng . Research progress on nanobiomedicine targeting mitochondrial homeostasis for improving myocardial ischemia. Chinese Chemical Letters, 2026, 37(5): 111843-. doi: 10.1016/j.cclet.2025.111843
13. [13]
  Kai Ye , Zhicheng Ye , Chuantao Wang , Zhilai Luo , Cheng Lian , Chunyan Bao . Artificial signal transduction triggered by molecular photoisomerization in lipid membranes. Chinese Chemical Letters, 2025, 36(4): 110033-. doi: 10.1016/j.cclet.2024.110033
14. [14]
  Yuhua Ma , Jiayuan Zhang , Yonghui Duan , Ziyu Zhang , Runtong Zhang , Zuhai Lei , Ben Shi , Yi Lu , Wei Wu , Haisheng He . Bergenin lipid prodrug nanoparticles: Synthesis, enhanced oral bioavailability, and mechanistic studies. Chinese Chemical Letters, 2026, 37(7): 112134-. doi: 10.1016/j.cclet.2025.112134
15. [15]
  Shiyue Zheng , Bokyeong Hwang , Eun Seo Kim , In-Jeong Lee , Xiaoqiang Chen , Yahui Chen , Hwan Myung Kim , Juyoung Yoon . Two-photon fluorescent probe for specific imaging of lipid droplets. Chinese Chemical Letters, 2026, 37(11): 112248-. doi: 10.1016/j.cclet.2025.112248
16. [16]
  Kun-Heng Li , Hong-Yang Zhao , Dan-Dan Wang , Ming-Hui Qi , Zi-Jian Xu , Jia-Mi Li , Zhi-Li Zhang , Shi-Wen Huang . Mitochondria-targeted nano-AIEgens as a powerful inducer for evoking immunogenic cell death. Chinese Chemical Letters, 2024, 35(5): 108882-. doi: 10.1016/j.cclet.2023.108882
17. [17]
  Bin Fang , Jiaqi Yang , Limin Wang , Haoqin Li , Jiaying Guo , Jiaxin Zhang , Qingyuan Guo , Bo Peng , Kedi Liu , Miaomiao Xi , Hua Bai , Li Fu , Lin Li . A mitochondria-targeted H₂S-activatable fluorogenic probe for tracking hepatic ischemia-reperfusion injury. Chinese Chemical Letters, 2024, 35(6): 108913-. doi: 10.1016/j.cclet.2023.108913
18. [18]
  Zhiyu Yu , Xiang Luo , Cheng Zhang , Xin Lu , Xiaohui Li , Pan Liao , Zhongqiu Liu , Rong Zhang , Shengtao Wang , Zhiqiang Yu , Guochao Liao . Mitochondria-targeted carrier-free nanoparticles based on dihydroartemisinin against hepatocellular carcinoma. Chinese Chemical Letters, 2024, 35(10): 109519-. doi: 10.1016/j.cclet.2024.109519
19. [19]
  Fan Zheng , Runsha Xiao , Shuai Huang , Zhikang Chen , Chen Lai , Anyao Bi , Heying Yao , Xueping Feng , Zihua Chen , Wenbin Zeng . Accurate visualization colorectal cancer by monitoring viscosity variations with a novel mitochondria-targeted fluorescent probe. Chinese Chemical Letters, 2025, 36(2): 109876-. doi: 10.1016/j.cclet.2024.109876
20. [20]
  Huiyang Chen , Zibo Li , Xiaoying Li , Chenhong Tang , Xiaoyu Liu , Minyi Nie , Ying Huang , Xiaoyu Chen , Kuncai Liu , Yilan Dai , Qiaoling Zhang , Ling Lin , Siming Zhang , Bingchen Zhang , Zhiqiang Yu . A novel mitochondria-targeted nanoprodrug amplifies oxidative stress to enhance cisplatin chemotherapy for the treatment of hepatocellular carcinoma. Chinese Chemical Letters, 2025, 36(10): 111313-. doi: 10.1016/j.cclet.2025.111313

Get Citation

PDF

XML

Metrics

PDF Downloads(0)
Abstract views(16)
HTML views(0)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142